Today, the Institute for Regenerative Medicine at Wake Forest University School of Medicine announced that the second phase of the Armed Forces Institute of Regenerative Medicine (AFIRM) project will move ahead with involvement from researchers on Stern Family Professor David Kaplan’s biomedical engineering team. The five-year, $75 million federally funded project focuses on applying regenerative medicine to battlefield injuries.
Anthony Atala, M.D., director of the Wake Forest Institute for Regenerative Medicine, is the lead investigator for AFIRM-II. He will direct a consortium of more than 30 academic institutions, including Tufts School of Engineering, and industry partners.
In the first phase of AFIRM, which began in 2008, Kaplan’s group looked at soft tissue reconstruction and peripheral nerve repair research. During this phase, Kaplan will focus on muscle regeneration.